Global Gene Panel Market, By Product & Service (Test Kits and, Testing Services), Technique (Amplicon-Based Approach and Hybridization-Based Approach), Design (Predesigned Gene Panels and Customized Gene Panels), Application (Cancer Risk Assessment, Diagnosis, and Pharmacogenetics), End-User (Hospitals & Clinics and, Research Organizations & Academic Institutes), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028
Gene Panel Market Analysis and Insights
Gene panel market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to reach at an estimated value of USD 3,644.66 million and grow at a CAGR of 8.10% in the above-mentioned forecast period. Rising prevalence of chronic diseases drives the gene panel market.
A gene panel is a defined as a test which helps in the analysis of multiple genes at the same time for cancer-associated mutations. This test is capable to examine numerous numbers of genes which helps in providing information about cancer and also provides a secure diagnostic to help preventing cancer to be spread. BRCA1 and BRCA2 are two types of genes which are responsible for the production of proteins that help in suppressing tumors and these proteins help in repairing damaged DNA and also prevent the growth of tumor cells.
Growing company initiatives is the vital factor escalating the market growth, also rising benefits of gene panels, rising numbers of company initiatives across the world coupled with benefits of gene panels, rising adoption of genetic testing, increasing technological advancements such as next generation sequencing system, increasing need for efficient prenatal diagnosis and increase in numerous types of cancer cases, including cancer of the fallopian tubes, ovaries, breasts in women, and prostate in men are the major factors among others driving the gene panel market. Moreover, rising government initiatives in population sequencing, rising emerging markets and increasing technological advancements and modernization in the healthcare techniques will further create new opportunities for gene panel market in the forecasted period of 2021-2028.
However, rising security concerns for the genetic data along with increasing stringent rules and regulations for the pharmaceutical companies and the increased cost of testing followed by erroneous results will obstruct the market growth, and will further challenge the growth of gene panel market in the forecast period mentioned above.
Gene panel market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on gene panel market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Gene Panel Market Scope and Market Size
Gene panel market is segmented on the basis of product & service, technique, design, application and end-user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- On the basis of product & service, gene panel market is segmented into test kits and testing services.
- Based on technique, the gene panel market is segmented into amplicon-based approach and hybridization-based approach.
- Based on design, the gene panel market is segmented into predesigned gene panels and customized gene panels.
- Based on application, the gene panel market is segmented into cancer risk assessment, diagnosis, and pharmacogenetics.
- The gene panel market is also segmented on the basis of end-user into hospitals & clinics and research organizations & academic institutes.
Gene Panel Market Country Level Analysis
Gene panel market is analysed and market size insights and trends are provided by country, product & service, technique, design, application and end-user as referenced above.
The countries covered in the gene panel market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the gene panel market due to rise in research on cancer and inherited rare diseases, increase in the number of NGS-based & clinical applications and increasing government support for genomics research and the presence of leading NGS providers in this region. Asia-Pacific is the expected region in terms of growth in gene panel market due to rise in health care awareness and increase in demand for advanced medical technology.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
Gene panel market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment’s, installed base of different kind of products for gene panel market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the gene panel market. The data is available for historic period 2010 to 2019.
Competitive Landscape and Gene Panel Market Share Analysis
Gene panel market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to gene panel market.
The major players covered in the gene panel market report are BGI, Illumina, Inc., Agilent Technologies, Inc, Eurofins Scientific, QIAGEN, OriGene Technologies, Inc., Bioneer Corporation, GenScript, Eurogentec, Twist Bioscience., BioCat GmbH, Thermo Fisher Scientific Inc, Novogene Co., Ltd, GENEWIZ, Inc., Integrated DNA Technologies, Inc, F. Hoffmann-La Roche Ltd, ArcherDX, Inc. and GATC Biotech AG, among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-